Sulzer Will Replace Heart Valve Testers In UK After Patient Death
This article was originally published in The Gray Sheet
Executive Summary
Sulzer Medica says it will wait until British authorities complete their investigation of a patient death related to a heart valve tester distributed by the company before addressing liability issues related to the case
You may also be interested in...
Zoll M Series AED Class I Recall To Be Complete By End Of Second Quarter
Zoll Medical reports that a worldwide recall of M Series biphasic automated external defibrillators is now 80% complete. Initiated in December 2001, the Class I recall appears in FDA's April 24 weekly enforcement report
Sulzer Orthopedics Inter-Op
Recall of acetabular shells for hip replacement affects roughly 17,750 devices implanted in the U.S. after October 1999, the company announces Dec. 8. Testing of the manufacturing process showed a low percentage of components having a residue of lubricant on the exterior porous surface, which may cause aseptic loosening of the shell, Sulzer explains. "Only a very small number of patients who have received one of these shells may require medical intervention other than post-operative monitoring," the firm says
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.